Table 3.
Statistical analysis of 50 differential metabolites in urine identified from the comparison of HSPN (+) vs. HSPN (–).
Differential metabolites | Retention time (min) | Mass-to-charge ratio | VIP | Fold change | P-valuea | Adduct |
---|---|---|---|---|---|---|
10,20-Dihydroxyeicosanoic acid | 10.71 | 362.3240 | 3.41 | 1.37 | <0.001 | M+NH4 |
7-Hydroxyoctadecanoic acid | 10.63 | 318.3003 | 3.16 | 1.27 | <0.001 | M+NH4 |
Choline* | 0.65 | 104.1070 | 3.15 | 1.44 | <0.001 | M+H |
5-Ethenylbenzene-1,2,3-triolb | 4.52 | 151.0406 | 2.84 | 0.58 | 0.002 | M–H |
Valyl-Leucine | 4.48 | 231.1698 | 2.83 | 6.08 | 0.005 | M+H |
Dodecanedioic acid | 7.23 | 231.1581 | 2.83 | 0.48 | 0.006 | M+H |
1,2,3,4-Tetrahydroisoquinoline | 7.27 | 134.0961 | 2.71 | 0.67 | 0.008 | M+H |
Dihydroxy-1H-indole glucuronide Ib | 2.94 | 324.0731 | 2.67 | 1.45 | 0.036 | M–H |
N-Acetyl-a-neuraminic acid | 0.75 | 310.1136 | 2.55 | 1.29 | 0.014 | M+H |
Perillic acid | 5.99 | 167.1063 | 2.41 | 0.57 | 0.007 | M+H |
Genistein 4′,7-O-diglucuronide | 5.18 | 623.1245 | 2.37 | 0.31 | <0.001 | M+H |
3-Phenylpropionylglycineb | 4.31 | 206.0827 | 2.36 | 1.69 | 0.004 | M–H |
3-Hydroxytetradecanedioic acidb | 6.91 | 273.1709 | 2.19 | 0.51 | 0.001 | M–H |
Cyclohexane | 6.00 | 107.0838 | 2.15 | 0.71 | 0.039 | M+Na |
2,6-Dimethylheptanoyl carnitine | 8.71 | 302.2325 | 2.10 | 0.62 | 0.008 | M+H |
Urocanic acidb | 2.41 | 137.0355 | 2.06 | 1.28 | 0.003 | M–H |
(3-Phenyloxiran-2-yl) methanolb | 7.46 | 149.0609 | 2.06 | 0.55 | 0.032 | M–H |
[N-acetylneuraminosyl (a2–6) lactosamine] | 0.83 | 675.2462 | 2.05 | 1.19 | 0.027 | M+H |
5-Ethyl-3-methoxybenzene-1,2,4-triol | 3.65 | 202.1068 | 2.03 | 0.78 | 0.037 | M+NH4 |
Alpha-CEHC glucuronideb | 7.58 | 453.1770 | 1.98 | 0.32 | 0.042 | M–H |
N-Acetylaminooctanoic acidb | 6.41 | 200.1296 | 1.97 | 1.29 | 0.002 | M–H |
5′-Carboxy-gamma-chromanol | 9.12 | 324.2163 | 1.91 | 0.64 | 0.023 | M+NH4 |
Creatine riboside | 0.75 | 264.1179 | 1.91 | 1.74 | 0.003 | M+H |
Pyruvic acidb* | 0.56 | 87.00843 | 1.90 | 0.77 | 0.003 | M–H |
Vanillic acid 4-O-sulfateb | 2.94 | 246.9922 | 1.85 | 0.61 | 0.010 | M–H |
Adenosine 2′,3′-cyclic phosphate | 2.79 | 330.0597 | 1.84 | 0.74 | 0.017 | M+H |
Androsterone glucuronide | 10.02 | 484.2900 | 1.82 | 0.64 | 0.049 | M+NH4 |
L-Hexanoylcarnitine | 5.93 | 260.1856 | 1.67 | 0.59 | 0.014 | M+H |
Adenosine* | 2.60 | 268.1037 | 1.64 | 0.74 | 0.006 | M+H |
Tyrosyl-Proline | 3.86 | 279.1333 | 1.62 | 0.66 | 0.018 | M+H |
6-Hydroxy-5-methoxyindole Glucuronide | 4.65 | 340.1028 | 1.60 | 0.72 | 0.013 | M+H |
8-Hydroxy-7-methylguanine | 2.89 | 182.0670 | 1.60 | 1.24 | 0.020 | M+H |
Threoninyl-Tyrosine | 6.32 | 283.1282 | 1.59 | 0.76 | 0.021 | M+H |
3-Hydroxy-4-aminopyridine | 0.74 | 111.0552 | 1.58 | 0.84 | 0.004 | M+H |
3-Furoic acidb | 0.55 | 111.0082 | 1.58 | 0.83 | 0.032 | M–H |
Alpha-Carboxy-delta-decalactoneb | 3.90 | 213.1135 | 1.55 | 0.67 | 0.017 | M–H |
4-Methoxybenzene-1,3-diolb | 4.33 | 139.0403 | 1.53 | 0.71 | 0.004 | M–H |
4-Hydroxybenzaldehydeb | 4.17 | 121.0294 | 1.50 | 1.74 | 0.007 | M–H |
Cis-vaccenic acid* | 11.56 | 300.2875 | 1.48 | 1.10 | 0.028 | M+NH4 |
(4-Ethyl-2,6-dihydroxyphenyl) Oxidanesulfonic acidb | 5.20 | 233.0127 | 1.48 | 0.64 | 0.017 | M–H |
Phenylbutyrylglutamine | 8.21 | 315.1326 | 1.41 | 0.78 | 0.040 | M+Na |
Pyrogallol-2-O-sulfateb | 2.77 | 204.9817 | 1.39 | 0.67 | 0.002 | M–H |
But-2-enoic acidb | 0.57 | 85.02898 | 1.39 | 0.87 | 0.024 | M–H |
Arginyl-Gamma-glutamate | 3.85 | 320.2052 | 1.38 | 0.75 | 0.019 | M+NH4 |
4-Ethylbenzaldehydeb | 7.89 | 133.0658 | 1.37 | 0.69 | 0.011 | M–H |
Heptanoylcarnitine | 7.10 | 274.2012 | 1.36 | 0.42 | 0.009 | M+H |
Pregnanediol-3-glucuronideb | 9.36 | 495.2969 | 1.31 | 0.64 | 0.005 | M–H |
p-Cresolb | 5.20 | 153.0557 | 1.21 | 0.72 | 0.011 | M+FA–H |
5-Decenoic acid | 8.73 | 171.1369 | 1.21 | 0.75 | 0.045 | M+H |
11,12,15-Trihydroxyeicosatrienoic acid | 8.75 | 372.2741 | 1.13 | 0.61 | 0.022 | M+NH4 |
means that the metabolites were confirmed with reference compounds.
The metabolites were listed in a decreasing order based on VIP values.
Fold change with a value >1 indicates a relatively higher concentration present in the HSPN (+) patients.
p-values from Mann–Whitney U-test;
means that the metabolite was detected in negative ion mode.